Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis

Ilana Chefetz; Eli Sprecher

doi:10.1016/j.bbadis.2008.10.008

Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis

Ilana Chefetz, Eli Sprecher

Research output: Contribution to journal › Review article › peer-review

40 Scopus citations

Abstract

Familial tumoral calcinosis refers to a group of disorders inherited in an autosomal recessive fashion. Hyperphosphatemic tumoral calcinosis is characterized by increased re-absorption of phosphate through the renal proximal tubule, resulting in elevated phosphate concentration and deposition of calcified deposits in cutaneous and subcutaneous tissues, as well as, occasionally, in visceral organs. The disease was found to result from mutations in at least 3 genes: GALNT3, encoding a glycosyltransferase termed ppGalNacT3, FGF23 encoding a potent phosphaturic protein, and KL encoding Klotho. Recent data showed that ppGalNacT3 mediates O-glycosylation of FGF23, thereby allowing for its secretion and possibly protecting it from proteolysis-mediated inactivation. Klotho was found to serve as a co-receptor for FGF23, thereby integrating the genetic data into a single physiological system. The elucidation of the molecular basis of HFTC shed new light upon the mechanisms regulating phosphate homeostasis, suggesting innovative therapeutic strategies for the management of hyperphosphatemia in common acquired conditions such as chronic renal failure.

Original language	English (US)
Pages (from-to)	847-852
Number of pages	6
Journal	Biochimica et Biophysica Acta - Molecular Basis of Disease
Volume	1792
Issue number	9
DOIs	https://doi.org/10.1016/j.bbadis.2008.10.008
State	Published - Sep 2009
Externally published	Yes

Bibliographical note

Funding Information:
We are grateful to our patients and their family members for their enthusiastic, and continuous support. We would like also to thank many collaborators for their invaluable contribution to the various studies reviewed above including Orit Topaz, Gabriele Richard, Margarita Indelman, Aryeh Metzker, Ulla Mandel, Mordechai Mizrachi, John G. Cooper, Polina Specktor, Vered Friedman, Gila Maor, Israel Zelikovic, Sharon Raimer, Yoram Altschuler, Mordechai Choder, Dani Bercovich, Jouni Uitto and Reuven Bergman. This work was supported in part by grants provided by the Israel Science Foundation, the Rappaport Institute for Research in the Medical Sciences, Technion, and NIH/NIAMS grant R01 AR052627.

Keywords

Calcinosis
FGF23
GALNT3
KLOTHO

Access

10.1016/j.bbadis.2008.10.008

OpenUrl availability

Full text

Cite this

@article{acbca13534734074bbb7c639666fbea2,

title = "Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis",

abstract = "Familial tumoral calcinosis refers to a group of disorders inherited in an autosomal recessive fashion. Hyperphosphatemic tumoral calcinosis is characterized by increased re-absorption of phosphate through the renal proximal tubule, resulting in elevated phosphate concentration and deposition of calcified deposits in cutaneous and subcutaneous tissues, as well as, occasionally, in visceral organs. The disease was found to result from mutations in at least 3 genes: GALNT3, encoding a glycosyltransferase termed ppGalNacT3, FGF23 encoding a potent phosphaturic protein, and KL encoding Klotho. Recent data showed that ppGalNacT3 mediates O-glycosylation of FGF23, thereby allowing for its secretion and possibly protecting it from proteolysis-mediated inactivation. Klotho was found to serve as a co-receptor for FGF23, thereby integrating the genetic data into a single physiological system. The elucidation of the molecular basis of HFTC shed new light upon the mechanisms regulating phosphate homeostasis, suggesting innovative therapeutic strategies for the management of hyperphosphatemia in common acquired conditions such as chronic renal failure.",

keywords = "Calcinosis, FGF23, GALNT3, KLOTHO",

author = "Ilana Chefetz and Eli Sprecher",

note = "Funding Information: We are grateful to our patients and their family members for their enthusiastic, and continuous support. We would like also to thank many collaborators for their invaluable contribution to the various studies reviewed above including Orit Topaz, Gabriele Richard, Margarita Indelman, Aryeh Metzker, Ulla Mandel, Mordechai Mizrachi, John G. Cooper, Polina Specktor, Vered Friedman, Gila Maor, Israel Zelikovic, Sharon Raimer, Yoram Altschuler, Mordechai Choder, Dani Bercovich, Jouni Uitto and Reuven Bergman. This work was supported in part by grants provided by the Israel Science Foundation, the Rappaport Institute for Research in the Medical Sciences, Technion, and NIH/NIAMS grant R01 AR052627.",

year = "2009",

month = sep,

doi = "10.1016/j.bbadis.2008.10.008",

language = "English (US)",

volume = "1792",

pages = "847--852",

journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",

issn = "0925-4439",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis

AU - Chefetz, Ilana

AU - Sprecher, Eli

N1 - Funding Information: We are grateful to our patients and their family members for their enthusiastic, and continuous support. We would like also to thank many collaborators for their invaluable contribution to the various studies reviewed above including Orit Topaz, Gabriele Richard, Margarita Indelman, Aryeh Metzker, Ulla Mandel, Mordechai Mizrachi, John G. Cooper, Polina Specktor, Vered Friedman, Gila Maor, Israel Zelikovic, Sharon Raimer, Yoram Altschuler, Mordechai Choder, Dani Bercovich, Jouni Uitto and Reuven Bergman. This work was supported in part by grants provided by the Israel Science Foundation, the Rappaport Institute for Research in the Medical Sciences, Technion, and NIH/NIAMS grant R01 AR052627.

PY - 2009/9

Y1 - 2009/9

N2 - Familial tumoral calcinosis refers to a group of disorders inherited in an autosomal recessive fashion. Hyperphosphatemic tumoral calcinosis is characterized by increased re-absorption of phosphate through the renal proximal tubule, resulting in elevated phosphate concentration and deposition of calcified deposits in cutaneous and subcutaneous tissues, as well as, occasionally, in visceral organs. The disease was found to result from mutations in at least 3 genes: GALNT3, encoding a glycosyltransferase termed ppGalNacT3, FGF23 encoding a potent phosphaturic protein, and KL encoding Klotho. Recent data showed that ppGalNacT3 mediates O-glycosylation of FGF23, thereby allowing for its secretion and possibly protecting it from proteolysis-mediated inactivation. Klotho was found to serve as a co-receptor for FGF23, thereby integrating the genetic data into a single physiological system. The elucidation of the molecular basis of HFTC shed new light upon the mechanisms regulating phosphate homeostasis, suggesting innovative therapeutic strategies for the management of hyperphosphatemia in common acquired conditions such as chronic renal failure.

AB - Familial tumoral calcinosis refers to a group of disorders inherited in an autosomal recessive fashion. Hyperphosphatemic tumoral calcinosis is characterized by increased re-absorption of phosphate through the renal proximal tubule, resulting in elevated phosphate concentration and deposition of calcified deposits in cutaneous and subcutaneous tissues, as well as, occasionally, in visceral organs. The disease was found to result from mutations in at least 3 genes: GALNT3, encoding a glycosyltransferase termed ppGalNacT3, FGF23 encoding a potent phosphaturic protein, and KL encoding Klotho. Recent data showed that ppGalNacT3 mediates O-glycosylation of FGF23, thereby allowing for its secretion and possibly protecting it from proteolysis-mediated inactivation. Klotho was found to serve as a co-receptor for FGF23, thereby integrating the genetic data into a single physiological system. The elucidation of the molecular basis of HFTC shed new light upon the mechanisms regulating phosphate homeostasis, suggesting innovative therapeutic strategies for the management of hyperphosphatemia in common acquired conditions such as chronic renal failure.

KW - Calcinosis

KW - FGF23

KW - GALNT3

KW - KLOTHO

UR - http://www.scopus.com/inward/record.url?scp=70249108544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249108544&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2008.10.008

DO - 10.1016/j.bbadis.2008.10.008

M3 - Review article

C2 - 19013236

AN - SCOPUS:70249108544

SN - 0925-4439

VL - 1792

SP - 847

EP - 852

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

IS - 9

ER -

Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this